← Search

Data · study · 2026

MULTI-OMIC PROFILING SUPPORTS THE DIFFERENTIAL DIAGNOSIS OF HISTIOCYTIC SARCOMA AND ITS MESENCHYMAL MIMICS

Listed in NCBI GEO

The differential diagnosis between histiocytic sarcoma (HS) and undifferentiated pleomorphic sarcoma (UPS) remains an underexplored area of histopathological and oncological relevance.

Description

Both entities are rare, high-grade neoplasms that may arise in soft tissue, skin, the nervous system, and the gastrointestinal tract, among other sites, predominantly in adult patients. Their clinical and morphological overlap may be underrecognized, partly due to the subspecialized structure of contemporary surgical pathology practice.

Comparative data on their natural history, treatment, and prognosis remain limited. Furthermore, while UPS is managed according to established international guidelines, no standardized treatment approach exists for HS. In this study, we compared the clinical, histopathological, and genetic features of three patient groups diagnosed with HS, UPS, and dedifferentiated liposarcoma (DLS) – control group.

Read the rest (2 more)

In a “real-life” diagnostic setting and based on a limited number of cases, we explore their diagnostic relevance, applying a comprehensive, multi-platform approach, including immunophenotyping, high-throughput sequencing, gene expression profiling, and methylome analysis. We demonstrated a substantial morphophenotypic overlap among the three neoplasms, while also identifying distinct features within each group. Histiocytic sarcoma samples were enriched for mutations in the MAPK pathway, along with other recurrent mutations characteristic of myeloid neoplasms, and exhibited a functional genetic signature consistent with derivation from mononuclear phagocytes.

In contrast, soft tissue sarcomas showed a markedly higher tumor mutational burden and evidence of Hippo pathway activation, as well as FGF/FGFR signaling.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 65% · Sequencing 75%
Provenance · 1 source records, 9 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34589315 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-arraysource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title